Loading...

INO INOVIO PHARMACEUTICALS INC Earnings Reports 8-K Filing

NV P

N

INOVIO PHARMACEUTICALS INC

(INO)

2025 8-K

Financial Results

Stock Offering Details

Sales Agreement Termination

Financial Results Announcement

Warrant Amendment

FDA BLA Acceptance

Stock Offering Announcement

8-K Filing Summary

Equity Offerings

Financial Statements

Financial Results

Financial Results

Financial Results Announcement

Grant of Performance-Based ...

Financial Results Announcement

Underwriting Agreement for ...

Reverse Stock Split

Stock Split and Amendment A...

Financial Results Announcement

FDA Feedback on Clinical Tr...

Financial Results Announcement

Settlement of Stockholder D...

Compensation Committee adop...

Earnings Reports

Financial Results Announcement

Costs Associated with Exit ...

External Links:

On November 10, 2025, Inovio Pharmaceuticals, Inc. announced its financial results for the quarter ended September 30, 2025, highlighting performance metrics in a press release. This filing is categorized under 'Quarterly Earnings Reports.'

AI Assistant

INOVIO PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.